148 related articles for article (PubMed ID: 36537297)
1. Curcumol inhibits breast cancer growth
Wei ZL; Juan W; Tong D; Juan LX; Sa LY; Jie HFM; Xiao G; Xiang LG; Jie HM; Xu C
Food Funct; 2023 Jan; 14(2):874-885. PubMed ID: 36537297
[No Abstract] [Full Text] [Related]
2. RNA-binding domain 2 of nucleolin is important for the autophagy induction of curcumol in nasopharyngeal carcinoma cells.
Liu G; Wang J; Han M; Li X; Zhou L; Dou T; Liu Y; HuangFu M; Guan X; Wang Y; Tang W; Liu Z; Li L; Ding H; Chen X
Phytomedicine; 2023 Jul; 115():154833. PubMed ID: 37137203
[TBL] [Abstract][Full Text] [Related]
3. Curcumol inhibits EBV-positive Nasopharyngeal carcinoma migration and invasion by targeting nucleolin.
Guan X; Yu D; HuangFu M; Huang Z; Dou T; Liu Y; Zhou L; Li X; Wang L; Liu H; Wang J; Chen X
Biochem Pharmacol; 2021 Oct; 192():114742. PubMed ID: 34428442
[TBL] [Abstract][Full Text] [Related]
4. Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells.
Li X; Liu H; Wang J; Qin J; Bai Z; Chi B; Yan W; Chen X
Phytother Res; 2018 Nov; 32(11):2214-2225. PubMed ID: 30069933
[TBL] [Abstract][Full Text] [Related]
5. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
6. Correction: Curcumol inhibits breast cancer growth
Zhou LW; Wang J; Dou T; Li XJ; Liu YS; Huang Fu MJ; Guan X; Liu GX; Han MJ; Chen X
Food Funct; 2023 Feb; 14(3):1796. PubMed ID: 36655723
[TBL] [Abstract][Full Text] [Related]
7. Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.
Liu H; Wang J; Tao Y; Li X; Qin J; Bai Z; Chi B; Yan W; Chen X
Life Sci; 2019 Mar; 221():354-361. PubMed ID: 30811964
[TBL] [Abstract][Full Text] [Related]
8. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
9. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
[TBL] [Abstract][Full Text] [Related]
10. ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway.
Li G; Zhang J; Xu Z; Li Z
Cancer Manag Res; 2020; 12():265-275. PubMed ID: 32021441
[TBL] [Abstract][Full Text] [Related]
11. Curcumol Alleviates the Inflammation of Nucleus Pulposus Cells via the PI3K/Akt/NF-κB Signaling Pathway and Delays Intervertebral Disk Degeneration.
He S; Fu Y; Yan B; Tan H; Li H; Li J; Huang D; Huang Z; Lai J; Feng H; Sun Z; Lan Z
World Neurosurg; 2021 Nov; 155():e402-e411. PubMed ID: 34450323
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
13. 10-Gingerol Targets Lipid Rafts Associated PI3K/Akt Signaling in Radio-Resistant Triple Negative Breast Cancer Cells.
Ediriweera MK; Moon JY; Nguyen YT; Cho SK
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664351
[TBL] [Abstract][Full Text] [Related]
14. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of NCL attenuates tumor formation and growth in HeLa cells by targeting the PI3K/AKT pathway.
Ying J; Pan R; Tang Z; Zhu J; Ren P; Lou Y; Zhang E; Huang D; Hu P; Li D; Bao Q; Li P
Cancer Med; 2022 Mar; 11(6):1454-1464. PubMed ID: 35128835
[TBL] [Abstract][Full Text] [Related]
16. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
Xu Y; Fang R; Shao J; Cai Z
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.
Wang J; Wu J; Li X; Liu H; Qin J; Bai Z; Chi B; Chen X
J Proteomics; 2018 Jun; 182():1-11. PubMed ID: 29684682
[TBL] [Abstract][Full Text] [Related]
18. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
20. Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway
Meng M; Yang Q; Ouyang Z; Yang Q; Wu X; Huang Y; Su Y; Chen S; Chen W
Acta Pharm; 2023 Mar; 73(1):75-90. PubMed ID: 36692465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
